CareDx
In Brief This Week: CareDx; Centogene; Exagen; VolitionRx; More
News items for the week of March 10, 2025
CareDx Q4 Revenues Grow 32 Percent on Strong Testing Services
The company beat analyst estimates on the top and bottom lines for both the fourth quarter and full-year 2024.
Federal Judge Overturns $96M Jury Verdict in Natera, CareDx Patent Case
A US District Court judge found Natera's claims of patent infringement invalid, while denying CareDx's motion for a new trial.
JP Morgan Healthcare Conference, Day 2: Thermo Fisher, Labcorp, Hologic, CareDx, More
Highlights from the first day included updates from several firms about their China businesses and M&A strategies.
Preliminary Earnings Roundup: Hologic, Exact Sciences, QuidelOrtho, Guardant Health, More
Numerous firms reported preliminary revenues along with other business updates on Sunday and Monday ahead of the annual JP Morgan Healthcare Conference.
Jan 2, 2025
360Dx Top 30 Rebounds in 2024, Rises 4 Percent
Nov 1, 2024
360Dx Top 30 Falls 3 Percent in October
Oct 15, 2024
CareDx Preliminary Q3 Revenues Rise 23 Percent
Aug 1, 2024
360Dx Top 30 Jumps 11 Percent in July
Jul 1, 2024
360Dx Top 30 Slides 2 Percent in June
Jun 4, 2024
360Dx Top 30 Rises 3 Percent in May
May 1, 2024
360Dx Top 30 Falls 6 Percent in April
May 1, 2024